AR and neoplasm: Our work shows that the presence of AR-GSRs at high variant allele frequency is associated with outlier, tumour-specific expression of rearrangement-dependent AR-V species that display androgen-independent, enzalutamide-resistant transcriptional activity and can support androgen-independent growth of LNCaP cells.